Back to Search
PAUL MARCOM, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1245314129Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
34546(NC)
Research & Publications (20)
The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers.
PMID 16897431·Breast Cancer Res Treat·2007
3-trial
The impact of sharing results of a randomized breast cancer clinical trial with study participants.
PMID 18543100·Breast Cancer Res Treat·2009
3-trial
Markers of oxidative status in a clinical model of oxidative assault: a pilot study in human blood following doxorubicin administration.
PMID 19476408·Biomarkers·2009
8-other
Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: results from a multicenter phase II trial.
PMID 19476859·J Am Coll Surg·2009
3-trial
Breast cancer. Clinical practice guidelines in oncology.
PMID 19200416·J Natl Compr Canc Netw·2009
6-review
An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer.
PMID 19638211·Breast Cancer Res·2009
4-observational
Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care.
PMID 19224362·Breast Cancer Res Treat·2009
8-other
Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxel.
PMID 18234424·Cancer Treat Rev·2008
4-observational
Primary systemic therapy in breast cancer: past lessons and new approaches.
PMID 19093262·Cancer Invest·2008
8-other
Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression.
PMID 18612148·J Clin Oncol·2008
4-observational
Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy.
PMID 18501061·Clin Breast Cancer·2008
2-rct
Benefit or bias? The role of surgery to remove the primary tumor in patients with metastatic breast cancer.
PMID 18438109·Ann Surg·2008
8-other
Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840.
PMID 18375893·J Clin Oncol·2008
3-trial
Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study.
PMID 17641362·Radiology·2007
4-observational
Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2.
PMID 17822557·J Transl Med·2007
3-trial
Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study.
PMID 17614302·Cancer·2007
4-observational
Hypermethylation of the breast cancer-associated gene 1 promoter does not predict cytologic atypia or correlate with surrogate end points of breast cancer risk.
PMID 17220331·Cancer Epidemiol Biomarkers Prev·2007
8-other
Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy.
PMID 16467094·Clin Cancer Res·2006
8-other
Genetic/familial high-risk assessment: breast and ovarian.
PMID 16451772·J Natl Compr Canc Netw·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4101 N ROXBORO ST
DURHAM, NC 27704 - Phone
- (919) 684-8111
Quick Facts
- NPI
- 1245314129
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile